Jiangying Cao

Shandong Second Medical University Weifang 261053 Shandong China +86 536 8462014 +86 536 8462014
Weifang, 846201, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Discovery of novel SIRT3 inhibitors with MLLr leukemia inhibitory potency.

Discovery of novel SIRT3 inhibitors with MLLr leukemia inhibitory potency.

Journal: RSC medicinal chemistry

Published: March 30, 2026

Discovery of Novel PCSK9-LDLR PPI Inhibitors by a Structural Modification Approach.

Discovery of Novel PCSK9-LDLR PPI Inhibitors by a Structural Modification Approach.

Journal: Drug development research

Published: March 18, 2026

Synthesis, biological and pharmacokinetic characterization of a novel leucine ureido derivative as a multi-target anticancer agent.

Synthesis, biological and pharmacokinetic characterization of a novel leucine ureido derivative as a multi-target anticancer agent.

Journal: RSC advances

Published: April 30, 2024

The ameliorative effect on chemotherapy-induced injury and tumor immunosuppressive microenvironment of the polysaccharide from the rhizome of Menispermum dauricum DC.

The ameliorative effect on chemotherapy-induced injury and tumor immunosuppressive microenvironment of the polysaccharide from the rhizome of Menispermum dauricum DC.

Journal: International journal of biological macromolecules

Published: December 15, 2023

Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis.

Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis.

Journal: Molecules (Basel, Switzerland)

Published: October 30, 2022

Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis.

Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis.

Journal: RSC advances

Published: May 09, 2021

Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC.

Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC.

Journal: Molecules (Basel, Switzerland)

Published: September 25, 2020

Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.

Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.

Journal: Bioorganic & medicinal chemistry

Published: December 27, 2018

Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.

Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.

Journal: Bioorganic & medicinal chemistry

Published: January 24, 2018

Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors.

Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors.

Journal: ChemMedChem

Published: November 04, 2017

Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

Journal: European journal of medicinal chemistry

Published: July 11, 2015

Rapid screening of aminopeptidase N inhibitors by capillary electrophoresis with electrophoretically mediated microanalysis.

Rapid screening of aminopeptidase N inhibitors by capillary electrophoresis with electrophoretically mediated microanalysis.

Journal: Electrophoresis

Published: June 07, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026